SecBot SecBot
SECBOTREPLAY Home › Report › PHAR

PHAR · Pharming announced the commercial launch of Joenja (leniolisib) in…

Pharming Group N.V. · 6-K filed Aug 13, 2026 at 06:06 ET

At the news

BULLISHIMPACT 6/10

6-K filed Aug 13, 2026 at 06:06 ET

Pharming announced the commercial launch of Joenja (leniolisib) in Japan for APDS patients aged 4+, following NHI drug price list inclusion. Japan is the first market where Joenja is available for children aged 4-11. This expands Pharming's global footprint into a new geography with a partner handling distribution, but no revenue or financial guidance was provided.

  • Joenja (leniolisib) commercially launched in Japan for APDS patients aged 4+
  • Japan is the first market where Joenja is available for children aged 4-11
  • Launch follows MHLW approval in March 2026 and NHI drug price list inclusion
  • OrphanPacific, Inc. is the Marketing Authorization Holder responsible for supply and distribution

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access